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Reliable data from South Africa emanating from WHO
recommendations for the Safe Motherhood programme
underscores HIV/AIDS as the most common cause of maternal
deaths. The strengthening of HIV services for pregnant women
especially in countries with a high burden of HIV infection will
reduce HIV-related and un-related maternal mortality rates.
High-quality and complete data on maternal deaths is a critical
foundation for reliably monitoring temporal trends in maternal
deaths, and causes thereof, but needs substantial strengthening in
many resource-constrained settings.
HIV/AIDS is an increasing contributor to direct and indirect
causes of maternal deaths in sub-Saharan Africa. A review of
published data on maternal deaths and its association with HIV
shows that reliable data come from the Confidential Enquiries
into Maternal Deaths from South Africa, population-based surveys
in sentinel populations, and facility-based data. Despite an
increase in knowledge of the HIV status of pregnant women and
the initiation of antiretroviral treatment, reversals in trends
towards increased maternal deaths are not being observed.
The strengthening of HIV services provides an opportunity
to alter HIV epidemic trajectories and reduce maternal
deaths.
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Introduction
In a recent commentary in the Lancet,1 the editor begged
an answer to the question ‘what is it going to take to stop
mothers dying?’ We argue, based on rigorously collected
data from South Africa, that the strengthening of HIV
services for pregnant women will make a substantial con-
tribution, especially in settings where women bear a
disproportionate burden of HIV infection. Notably of the
health-related Millennium Development Goals, the least
progress has been made on reducing maternal deaths, and
indeed some resource-constrained settings have seen rever-
sals in the gains made in the early 1990s.
HIV and maternal deaths
Despite the already high burden of HIV infection in sub-
Saharan Africa, HIV continues to spread unabatedly.2 Each
year, there are more than 2 million pregnancies in HIV-
infected women in the world, with the majority occurring
in sub-Saharan Africa where access to HIV services remain
limited.3 Every year approximately 250 000 African women
die during pregnancy, delivery, or the puerperium,
accounting for 50% of the global burden of maternal
deaths.4
There is a close correlation in sub-Saharan Africa
between the increasing burden of HIV infection and the
simultaneous increase in maternal deaths,5 and there is
increasing evidence that HIV infection is becoming the
major cause of maternal mortality in resource-constrained
settings. The lack of complete data on the causes of
maternal deaths for most sub-Saharan countries limits our
ability to quantify the attributable risk of HIV/AIDS, or
project with accuracy the number of maternal deaths that
could be averted by strengthening HIV services for preg-
nant women.




Recently published global estimates for maternal mortal-
ity, based on an assessment of levels and trends in maternal
mortality for 181 countries,5 highlight the impact of HIV
on maternal mortality, and suggest that progress in reduc-
ing maternal mortality has been slowed by the HIV
pandemic.
Evidence of link between HIV and
maternal deaths from South Africa
In South Africa, the Saving Mothers report,6 based on data
collected between 2005 and 2007, indicates that HIV/AIDS
accounted for approximately 43.7% of facility-based
maternal deaths, and for about a ten-fold increased risk
of maternal deaths. This is a conservative estimate, as the
HIV status for 37.7% of the cases were unknown.6 Thus,
indirect causes of maternal deaths because of HIV/AIDS
have surpassed direct obstetric causes (hypertensive disor-
ders of pregnancy, 15.7%; obstetric haemorrhage, 12.4%;
and pregnancy-related sepsis, 9%) of maternal deaths in
South Africa. The process of reporting information on
confidential enquires into maternal deaths in South Africa
is published in the Saving Mothers report published
triennially.6
Independently undertaken, single facility-based audits
carried out in South Africa have also shown higher rates of
maternal mortality in HIV-infected women compared with
HIV-uninfected women.7,8 Data have been published from
two studies at a major tertiary hospital in KwaZulu-Natal
(the epicentre of the pandemic): in the first, Khan et al.7
in 2001 demonstrated a 32-fold increased risk of death
among TB–HIV co-infected women, compared with those
without HIV infection; and in the second study, Ramagoale
et al.8 in 2007 reported that the majority of deaths among
HIV-infected women were associated with co-infection
with tuberculosis (22%), pneumonia (19.9%), and menin-
gitis. More recently, a 5-year review of maternal deaths at a
tertiary health facility in Johannesburg, South Africa, shows
that maternal mortality ratios in HIV-infected women were
776/100 000 (95% CI 591–1000/100 000 births), and were
6.2-fold higher (95% CI 3.6–11.4) than in HIV-negative
women (124/100 000; 95% CI 72–199/100 000 births).9
These authors reported that although HIV testing rates
increased from 43.4 to 72.2% during this period, it
remained suboptimal, and could explain why although
59.2% of HIV-infected pregnant women with known HIV
status had been initiated on antiretroviral treatment, its
impact on life expectancy was not yet evident. They there-
fore suggested that an updated assessment of the effects of
HIV on maternal morbidity is needed, and that an acceler-
ated preparation plan and initiation of HIV treatment may
considerably reduce the high maternal mortality figures
associated with HIV.9
The Saving Mothers report (2005–2007) also found that
only 60% of mothers who died had had an HIV test, and
of these, 78.9% tested positive. The criteria used for assign-
ing cause of death as AIDS in the Saving Mothers report,
was very conservative. The women had to have had a posi-
tive HIV test and a cluster of differentiation 4 (CD4) count
of <200 cells/ll or an AIDS-defining condition to minimise
bias with respect to a mistaken diagnosis as a cause of
maternal death. It is worth noting that for 27.8% (255/915)
of maternal deaths, where cause of death was labelled as
AIDS, mothers also had an obstetric condition that could
have been assigned as the cause of death. A total of 58
women with AIDS had an abortion, another 16 women
with AIDS had the final cause of death reported as hypovo-
laemic shock associated with postpartum haemorrhage, and
an additional 181 women were recorded as having died of
septic shock, which could be classified as puerperal sepsis.6
Even if these deaths were reclassified as direct causes of
maternal deaths, then 78.9%, or about four out of five,
maternal deaths where the HIV status was known would
still be attributable to HIV. Based on this data, there is no
doubt that HIV infection is the largest threat to maternal
mortality in South Africa.
Reports from other parts of sub-Saharan Africa have also
shown that the risk of maternal death in HIV-infected
women is higher than in uninfected women, by as much as
five-fold.10–13 A 12-month prospective cohort study of the
natural history of HIV infection and transmission from
mothers to infants, in Malawi, Zambia and Tanzania,11
found that there were no deaths among the 331 HIV-unin-
fected women, whereas in 2292 HIV-infected mothers,
42 (1.8%) died. Ninety percent of the mothers died in the
postpartum period, and the authors speculate that underly-
ing health status, such as anaemia and malaria, could have
influenced this outcome.11 In sub-Saharan Africa, anaemia
is the leading cause of morbidity, and is mainly caused by
malaria, intestinal parasites and HIV.11,12 A prospective
mortuary investigation of all deaths in women aged 15–
44 years in Pointe Noire, Congo, for a period of 112 con-
secutive days, indicated that the maternal mortality rate
(MMR) was 32 times higher (95% CI 25–39) among HIV-
infected than HIV-uninfected women.14 In Uganda and
Zimbabwe, a comparison of morbidity and mortality
patterns in HIV-infected and uninfected women during
pregnancy, and in the subsequent 2 years, showed that
HIV-infected women were more likely to be admitted to
hospital or die during the 2 years after delivery than the
HIV-uninfected pregnant women.15 Data from a commu-
nity randomised trial conducted in the Rakai district of
Uganda reported that maternal mortality ratios in HIV-
infected mothers was 1686.8/100 000 live births compared
with 309.8/100 000 live births in HIV-uninfected women
(RR 5.44; 95% CI 1.98–14.93).12
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In contrast, in well-resourced countries, because of the
relatively small HIV epidemic in women, data on the con-
tribution of HIV to maternal mortality is limited. A study
from the USA reported that HIV-infected women undergo-
ing caesarean section were at a significantly greater risk of
mortality than uninfected women, and were twice as likely
to have one or more postpartum morbidities compared
with HIV-uninfected pregnant women (16.1 versus 8.5%,
P < 0.001).16
HIV-related maternal deaths: an
underestimate?
A key reason that the data from the Saving Mothers report
is an underestimate of true maternal deaths, including
those associated with HIV, is because it is based on facility-
based reports, and not all mothers utilise healthcare facili-
ties for antenatal, intrapartum, or postpartum care.6
Population level data on maternal deaths are available
from two rural sites in South Africa. Vital statistics have
been gathered by the Africa Centre from the Hlabisa sub-
district in northern KwaZulu-Natal province, South Africa,
in 6-monthly intervals from 2000, and includes about
86 000 people in 11 000 households.17 A follow-up visit is
conducted in all households where a death has occurred,
and a verbal autopsy is completed to ascertain the cause of
death using The International Statistical Classification of
Diseases and Related Health Problems 10th Revision (ICD-
10), as well as circumstances and geographical location of
death. The temporal trend analysis of this data (pers.
comm., W Graham) from 2000–2007 indicate that of the
11 274 deaths that occurred during this period, 151 were
maternal deaths (defined as a death up to 90 days follow-
ing delivery). About two-thirds (62.8%) of the maternal
deaths were in hospital, 31.7% were at home, and 6% were
unknown/missing data, and 59% of the deaths occurring at
home were to the result of AIDS or tuberculosis. These
data are related to deaths up to 90 days following deliv-
ery.17 Similar population-based surveys from the Agincourt
site demonstrated 26 maternal deaths over the period
2000–2007.18 Six of these maternal deaths occurred at
home (23.1%). Based on these two population-based sur-
veys, the number of home deaths in South Africa ranges
from 23.1 to 37.7%.
Population-based estimates remain rare globally. Data
from other resource-constrained settings demonstrate that
maternal deaths that occur at home range from 14 to 68%.19
Not surprisingly, the estimates of maternal deaths of
147/100 000 live births reported in the Saving Mothers
report are conservative.
Using data from the 2001 census of South Africa on
external causes and maternal mortality led to estimates of
542/100 000 live births.20 The authors of the South African
census 2001 data state that this level of maternal deaths is
much higher than the estimates pre-dating the HIV/AIDS
era. The main reasons given for these excessive levels were
HIV/AIDS.20
Does pregnancy advance HIV disease?
One question raised by HIV and maternal mortality is the
nature of the interaction of HIV with pregnancy. Does the
dual immune-suppression from pregnancy and the advanc-
ing HIV disease work antagonistically, and lead to a more
rapid HIV disease progression? Although the initial views
were that increased morbidity and mortality was associated
with clinical progression, as adjudged by CD4 counts and
viral loads, recent evidence suggests that pregnancy appears
to have no discernable effect in increasing the progression
of HIV disease in asymptomatic HIV-infected women,21,22
but that symptomatic HIV-infected women are at a greater
risk of dying from infectious diseases than uninfected preg-
nant women. The most commonly occurring opportunistic
infections in HIV-infected pregnant women in resource-
constrained settings include common treatable infections
such as bronchopneumonia, Pneumocystis carinii pneumo-
nia, meningitis, tuberculosis, and malaria.6,23 More aggres-
sive efforts to prevent, diagnose, and treat these conditions
prior to and during pregnancy will reduce morbidity and
mortality in HIV-infected pregnant women.
Strategies for reducing maternal
deaths
Based on the data, enhancing our knowledge of HIV status
in pregnant women and their sexual partners, more aggres-
sive diagnosis and treatment of common co-morbidities,
and focussing more critically on the postpartum period are
the obvious areas that need strengthening. Not surpris-
ingly, the solutions for reducing HIV-related maternal
deaths are similar to that for reducing overall maternal
mortality, namely establishing political will and working
within a human-rights framework that includes maternal
rights, strengthening health systems, effective policies, and
encouraging community participation and social mobilisa-
tion that underscores the importance of saving mothers’
lives.24 Fortney and Leong24 describe a systematic three-
step approach to reducing maternal mortality, namely: (1)
prevent unwanted pregnancies; (2) prevent complications
from occurring during pregnancy, delivery, and the post-
partum period; and (3) prevent deaths when complications
occur. This approach resonates with the WHO four-
component universal strategic plan to reduce transmission
of HIV to infants, namely: (1) primary prevention of HIV
among women of child-bearing age; (2) preventing unin-
tended pregnancy in HIV-infected women; (3) preventing
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mother-to-child transmission (PMTCT) of HIV during
pregnancy; and (4) providing treatment, care, and support
for infected women and their families.
Preventing pregnancy
Each year approximately 80 million women, regardless of
HIV status, have unwanted pregnancies.25 Strengthening
efforts to prevent these unwanted pregnancies, particularly
in HIV-infected women, would be the single most effective
means of preventing maternal deaths.24 This can be achieved
through increasing awareness, understanding obstacles to
contraceptive use, and making acceptable family planning
methods readily accessible and affordable.26–28 Aggressive
campaigns to promote family planning in continents with
high birth rates like Asia and Africa has the potential to
avert 150 000 (32%) of all maternal deaths globally.26
In 2002, despite only 13% of married women aged 15–
49 years in sub-Saharan Africa using modern contraceptive
methods, an estimated 22% (or 173 000) of HIV-positive
births were prevented.26 The cost effectiveness of family
planning programmes to avert HIV-positive births has been
assessed using a hypothetical sub-Saharan African popula-
tion, and demonstrate that for the same costs, the contra-
ceptive strategy could avert 28.6% more HIV-positive births
than the two-dose nevirapine intervention for PMTCT,27
and thereby reduce both maternal and infant deaths.
Health systems should maximise access to family plan-
ning services and ensure that every opportunity is seized to
offer a variety of contraceptive methods. Opportunities
such as the time of discharge from maternity units, postna-
tal clinics, when mothers bring children for immunisations,
and the post-abortion and the postpartum periods are also
excellent windows of opportunity that should not be
missed. It is more effective to discuss contraception at these
points than to refer women to another health facility or to
ask them to return at a later date.27 In cases of HIV-
infected women attending dedicated clinics, opportunities
must be taken to offer contraception at each visit.
Although unsafe abortion rates have declined by 17% in
the past 10 years (from 35 to 29/1000 women of childbear-
ing age), maternal mortality resulting from abortions
remained static at 70 000 deaths per year.29,30 The Saving
Mothers report found that deaths from unsafe abortions
have increased since the previous report. Improving access
to, and increasing the number of health facilities providing
access to legal abortion services would decrease deaths from
abortion.6 Obviously, access and the availability of services
is essential, but so too is the importance of improving the
quality of the termination of pregnancy services. Health
services must in addition provide contraception at all levels
of health care, and provide abortion services at the lowest
level of the health service.
Prevention of HIV
Abstinence, fidelity, the consistent use of condoms,
monogamous relationships, awareness of one’s HIV sta-
tus, and more recently, mass male circumcision (MMC)
have become the cornerstones of global HIV prevention
efforts. Notwithstanding the need for methods that can
be initiated by women, knowledge of HIV status is an
important gateway to access of prevention and treatment
services. Thus, offering HIV testing and counselling to all
women whenever an opportunity presents (during the
antenatal period, following delivery of the unbooked
mother, and at the time of immunisation of the baby),
is an important strategy, particularly because voluntary
counselling and testing (VCT) has been shown to be
effective in reducing risky sexual behaviour, and is cost-
effective as a preventative intervention.31,32 However,
large numbers of people in sub-Saharan Africa decline
testing because of the fear of stigma and discrimination.
These obstacles together with weak laboratory systems,
such as the lack of laboratory services for CD4 counts,
and the delay in obtaining results, hinder the uptake of
VCT in the PMTCT programmes.33
Recently, MMC has been promoted as an HIV-preventa-
tive strategy based on compelling evidence of protection
from three independently conducted randomised controlled
trials.34–36 This provides a wonderful opportunity to target
men for VCT services, and get them more engaged in HIV-
prevention efforts, including saving mothers and taking
greater responsibility as fathers.37
Preventing complications
The prevention of complications plays an important role in
obstetric practice and much of the prevention activities
have been described previously, and these strategies are
instituted during the antenatal, intrapartum, and postpar-
tum periods.21–24
Specifically related to HIV-associated morbidity and
deaths, is good nutrition, which includes sufficient quanti-
ties of iron, iodine, folic acid and vitamin A. Anaemia has
been reported to be an important co-factor in HIV-related
maternal deaths.11 Identifying and treating anaemia is
therefore vitally important, not only as a general nutritional
measure, but to prevent complications associated with
malaria, HIV/AIDS, hepatitis and sickle-cell anaemia. There
is also evidence that providing vitamin A to women during
pregnancy may, in addition to improving their own health,
prevent death, which is most likely to originate in the
intrapartum period.38
More recently, Kirkwood et al. (2010) did a similar trial
to the Nepal study on vitamin A supplementation as a safe
motherhood or child survival strategy. Their findings do
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not support the use of low-dose vitamin A supplementa-
tion for women in their reproductive phase of life to
reduce maternal mortality.39
The implementation of obstetric practices such as keep-
ing the amniotic membranes intact during labour, limiting
the number of vaginal examinations, performing episioto-
mies only if necessary, and preventing prolonged labour,
may reduce postpartum infections, and therefore postpar-
tum morbidity and death.21,22,40 There is some evidence
that the use of prophylactic antibiotics in HIV-infected
labouring women may reduce postpartum infectious mor-
bidity, particularly in those who had episiotomies.40 In a
randomised trial conducted in Durban, South Africa, HIV-
positive pregnant women in whom vaginal delivery was
anticipated, were allocated to receive Cefoxitin or placebo
in labour: those that received antibiotics had a 53% reduc-
tion in postpartum endometritis.40 However, in a recent
placebo-controlled trial, the administration of perinatal and
prenatal antibiotics during pregnancy in 1558 women had
no effect on maternal mortality and morbidity among
HIV-infected pregnant Zambian, Malawian, and Tanzanian
women.41 Further studies on the use of prophylactic antibi-
otics in HIV-infected women to reduce maternal mortality
are required.
The Saving Mothers report indicates that bacterial pneu-
monias, bacterial sepsis, atypical pneumonia, cryptococcal
meningitis, and tuberculosis are common co-morbid condi-
tions associated with HIV/AIDS, and may be the primary
causes of maternal death.6 HIV and tuberculosis co-infec-
tion has emerged as a substantial contributor to maternal
deaths in sub-Saharan Africa.42 Tuberculosis is rampant in
sub-Saharan Africa, and maternal mortality studies show
that tuberculosis was the third leading infectious cause of
maternal death in Durban (14.9%)7 and in Lusaka
(25%),43 where 33 of 36 women were infected with HIV.
These observations strongly indicate that in Africa, where
antenatal care may be the first encounter a woman has
with the health system, effective interventions to screen and
treat for these conditions must be prioritised and instituted
into routine antenatal packages at all levels of health care.
In South Africa, although screening for tuberculosis during
pregnancy is recommended, it does not seem to be under-
taken routinely.9 This may contribute to a delay in diagno-
sis, and considerable morbidity and even mortality.
Screening for malaria and prophylactic anti-malarial
therapy in the relevant countries is also of value.42 Further-
more, cotrimoxazole prophylaxis has been shown to
decrease the number of episodes of pneumonia. Similarly,
isoniazid (INH) prophylaxis may be of value.42
Postnatal care is poor in African countries, and puerperal
sepsis is a major cause of maternal mortality. Following
delivery, women should remain in hospital for at least
24 hours or more, and the need for postnatal care and
follow-up is essential. Women should be informed of
the warning signs of infection, and to return prior to the
routine 6–7-day postnatal follow-up visit if necessary.
Clinical experience suggests that HIV-infected women may
be clinically well at the time of discharge, but are re-admit-
ted with florid sepsis 7–10 days following delivery.6,39 Thus
strengthening postnatal care in sub-Saharan countries is of
paramount importance.
Human resources
Most, if not all countries, have chronic shortages of human
resources for health. In sub-Saharan countries, the HIV epi-
demic has also had a significant negative impact on health-
care professionals in countries with the highest rates of
infection. In Botswana, 17% of the health workforce died
from diseases related to AIDS between 1999 and 2005.44
In South Africa, the prevalence of HIV among health profes-
sionals approximates that of the general population, leading
to higher rates of illness and absenteeism among the very
people needed to provide health services.45 Combined with
a ‘brain drain’, Samb et al.46 state that ‘in a vicious circle,
the epidemic fuels the crisis in the health workforce at the
same time the shortage of health workers presents a major
barrier to preventing and treating the disease’.
Achieving a goal of universal access to comprehensive
HIV prevention programmes, treatment, and care and sup-
port, however, cannot be achieved without strengthening
healthcare systems and the significant expansion of health
workforces. One way to expand the health workforce is by
‘task shifting’, the process of delegation, in which tasks are
moved where appropriate from more to less specialised
health workers.46 This allows for the more efficient use of
the available overall workforce. Although the term ‘task
shifting’ is new, the concept of such practices has existed
for some time outside HIV-related services. For example,
in South Africa, specially trained midwives manage mater-
nity units at a primary health care clinic level. In addition,
PMTCT trained nurses and antiretroviral treatment (ART)
nurses are the unofficial gatekeepers of HIV knowledge and
skills at the primary health care level.47 These categories of
trained health workers direct HIV testing and counselling
services, prepare pregnant women for antiretroviral therapy
initiation, and partner with midwives to provide PMTCT
services during the perinatal period.47 Such practices have
been shown to be feasible and acceptable, and are associ-
ated with favourable outcomes.48,49
Conclusion
Maternal mortality rates in poorly resourced countries are
unacceptably high. In countries with high rates of HIV infec-
tion, maternal mortality ratios have increased further, and
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HIV/AIDS is now the most common non-obstetric infectious
cause of maternal deaths. In sub-Saharan Africa, HIV/AIDS
has thus become a human developmental issue, because it
diminishes the chances of alleviating poverty, achieving uni-
versal primary education, promoting gender equality, and
reducing child and maternal mortality. The challenges
require a renewed global effort because HIV continues to
spread in under-resourced settings, and, globally, women are
bearing an increasing burden of HIV infection. Recent
reports from the USA highlight the emerging HIV epidemic
in minority women at rates comparable with several African
countries,50,51 and underscore the importance of more global
attention and effort being directed at the attributable risk to
maternal deaths through HIV.
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